429 related articles for article (PubMed ID: 15860580)
1. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.
Xin L; Lawson DA; Witte ON
Proc Natl Acad Sci U S A; 2005 May; 102(19):6942-7. PubMed ID: 15860580
[TBL] [Abstract][Full Text] [Related]
2. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.
Watabe T; Lin M; Ide H; Donjacour AA; Cunha GR; Witte ON; Reiter RE
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):401-6. PubMed ID: 11752398
[TBL] [Abstract][Full Text] [Related]
3. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
[TBL] [Abstract][Full Text] [Related]
4. Stem cell genes in androgen-independent prostate cancer.
Bui M; Reiter RE
Cancer Metastasis Rev; 1998-1999; 17(4):391-9. PubMed ID: 10453283
[TBL] [Abstract][Full Text] [Related]
5. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential.
Kwon OJ; Zhang L; Xin L
Stem Cells; 2016 Jan; 34(1):191-202. PubMed ID: 26418304
[TBL] [Abstract][Full Text] [Related]
7. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.
Jiao J; Hindoyan A; Wang S; Tran LM; Goldstein AS; Lawson D; Chen D; Li Y; Guo C; Zhang B; Fazli L; Gleave M; Witte ON; Garraway IP; Wu H
PLoS One; 2012; 7(8):e42564. PubMed ID: 22880034
[TBL] [Abstract][Full Text] [Related]
9. Identification of a cell of origin for human prostate cancer.
Goldstein AS; Huang J; Guo C; Garraway IP; Witte ON
Science; 2010 Jul; 329(5991):568-71. PubMed ID: 20671189
[TBL] [Abstract][Full Text] [Related]
10. Basal epithelial stem cells are efficient targets for prostate cancer initiation.
Lawson DA; Zong Y; Memarzadeh S; Xin L; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2610-5. PubMed ID: 20133806
[TBL] [Abstract][Full Text] [Related]
11. Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
Park JW; Lee JK; Phillips JW; Huang P; Cheng D; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4482-7. PubMed ID: 27044116
[TBL] [Abstract][Full Text] [Related]
12. Prostate stem cells and prostate cancer.
Lawson DA; Xin L; Lukacs R; Xu Q; Cheng D; Witte ON
Cold Spring Harb Symp Quant Biol; 2005; 70():187-96. PubMed ID: 16869753
[TBL] [Abstract][Full Text] [Related]
13. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
Wang S; Garcia AJ; Wu M; Lawson DA; Witte ON; Wu H
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1480-5. PubMed ID: 16432235
[TBL] [Abstract][Full Text] [Related]
14. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptors in early and castration resistant prostate cancer: friend or foe?
Pelekanou V; Notas G; Stathopoulos EN; Castanas E; Kampa M
Hormones (Athens); 2013; 12(2):224-35. PubMed ID: 23933691
[No Abstract] [Full Text] [Related]
16. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model.
Korsten H; Ziel-van der Made A; Ma X; van der Kwast T; Trapman J
PLoS One; 2009 May; 4(5):e5662. PubMed ID: 19461893
[TBL] [Abstract][Full Text] [Related]
17. Computational causal reasoning models of mechanisms of androgen stimulation in prostate cancer.
Pratt D; Hahn W; Matthews A; Febbo P; Berger R; Duckworth B; Levy J; Segaran T; Sun J; Ladd B; Elliston K
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():38. PubMed ID: 17946775
[No Abstract] [Full Text] [Related]
18. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Huss WJ; Gray DR; Greenberg NM; Mohler JL; Smith GJ
Cancer Res; 2005 Aug; 65(15):6640-50. PubMed ID: 16061644
[TBL] [Abstract][Full Text] [Related]
19. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
[TBL] [Abstract][Full Text] [Related]
20. Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations.
Ceder JA; Aalders TW; Schalken JA
Stem Cell Res Ther; 2017 Apr; 8(1):95. PubMed ID: 28446230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
